An antiviral mechanism investigated with ribavirin as an RNA virus mutagen for foot-and-mouth disease virus.
To prove whether error catastrophe/lethal mutagenesis is the primary antiviral mechanism of action of ribavirin against foot-and-mouth disease virus (FMDV). Ribavirin passage experiments were performed and supernatants of Rp1 to Rp5 were harvested. Morphological alterations as well as the levels of viral RNAs, proteins, and infectious particles in the BHK-21 cells infected using the supernatants of Rp1 to Rp5 and control were measured by microscope, real-time RT-PCR, western-blotting and plaque assays, respectively. The mutation frequency was measured by sequencing the complete P1- and 3D-encoding region of FMDV after a single round of virus infection from ribavirin-treated or untreated FMDV-infected cells. Ribavirin treatment for FMDV caused dramatically inhibition of multiplication in cell cultures. The levels of viral RNAs, proteins, and infectious particles in the BHK-21 cells infected were more greatly reduced along with the passage from Rp1 to Rp5, moreover, nucleocapsid protein could not be detected and no recovery of infectious virus in the supernatant or detection of intracellular viral RNA was observed at the Rp5-infected cells. A high mutation rate, giving rise to an 8-and 11-fold increase in mutagenesis and resulting in some amino acid substitutions, was found in viral RNA synthesized at a single round of virus infection in the presence of ribavirin of 1000 microM and caused a 99.7% loss in viral infectivity in contrast with parallel untreated control virus. These results suggest that the antiviral molecular mechanism of ribavirin is based on the lethal mutagenesis/error catastrophe, that is, the ribavirin is not merely an antiviral reagent but also an effective mutagen.
Gu
Chao-jiang
CJ
State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.
Zheng
Cong-yi
CY
Zhang
Qian
Q
Shi
Li-li
LL
Li
Yong
Y
Qu
San-fu
SF
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002460:Cell Line; D048430:Cell Shape; D006224:Cricetinae; D029544:Foot-and-Mouth Disease Virus / Q000187:drug effects / Q000235:genetics; D006801:Humans; D009153:Mutagens; D012328:RNA Viruses / Q000187:drug effects / Q000235:genetics; D012367:RNA, Viral / Q000187:drug effects; D012254:Ribavirin / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D009153:Mutagens; D012367:RNA, Viral; D012254:Ribavirin